Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
6th Japan Bioanalysis Forum Symposium: challenge of regulated bioanalysis
1GlaxoSmithKline K.K., 4-6-15, Sendagaya, Shibuya-ku, Tokyo, 151-8566, Japan.
Abstract:
Biomarker measurement and LC-MS analysis of large molecule pharmaceuticals (LM-MS) are becoming increasingly important in pharmaceutical development, although they are not included in the existing bioanalytical method validation guidelines in Japan. The 6th Japan Bioanalysis Forum symposium presented challenges regarding biomarkers and LM-MS, as well as the current circumstances for regulated bioanalysis, by inviting speakers from Japan, the USA, European Union and Asia-pacific. Japan Bioanalysis Forum discussion groups also presented their outcomes and openly discussed these with the attendees - over 200 dedicated individuals from industry, regulatory agencies and academia. The symposium successfully reinforced the idea that fit-for-purpose approaches are necessary, and that science should drive any judgments and actions throughout drug development.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Measurement of Bioavailability: Pharmacodynamic Methods

